CN100381155C - Medicine for treating mammary glands hyperplasia - Google Patents
Medicine for treating mammary glands hyperplasia Download PDFInfo
- Publication number
- CN100381155C CN100381155C CNB2006100812419A CN200610081241A CN100381155C CN 100381155 C CN100381155 C CN 100381155C CN B2006100812419 A CNB2006100812419 A CN B2006100812419A CN 200610081241 A CN200610081241 A CN 200610081241A CN 100381155 C CN100381155 C CN 100381155C
- Authority
- CN
- China
- Prior art keywords
- medicine
- radix
- root
- chinese
- hypernlasia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a medicine for treating hypernlasia of the mammary gland, which belongs to the field of Chinese medicines. The medicine is prepared from Chinese medicines of the following proportion by weight: 5 to 15 of bupleurum root, 8 to 16 of red sage root, 10 to 20 of Chinese angelica, 10 to 20 of white peony root, 25 to 35 of milkvetch root, 25 to 35 of coix seed, 8 to 12 of platycodon root, 8 to 12 of fructus aurantii, 8 to 12 of green tangerine peel, 10 to 20 of trichosanthes, 10 to 20 of seaweed, 8 to 12 of nutgrass galingale rhizome and 10 to 20 of corydalis. Most patients have a good impression on the medicine for several years, and the curative effects of the medicine are as good as those of Chinese patent medicines in the market, such as Rukangpian, Ruzengning, etc. Until now, the medicine totally treats 3123 patients with hypernlasia of the mammary gland. The clinical observation proves that the medicine of the present invention has unique curative effects on various kinds of hypernlasia of mammary gland.
Description
Technical field
The present invention is a kind of medicine for the treatment of cyclomastopathy, belongs to the field of Chinese medicines.
Background technology
Mastopathy also has many benign breast diseases except the breast carcinoma of serious harm WomanHealth and life.Wherein, the highest with the cyclomastopathy sickness rate especially, the traditional Chinese medical science should disease the category of ownership " nodules of the breast disease ".Adult women's sickness rate is 57.8%～62.6% more than 30 years old.The possibility of canceration is very easily obscured and had to some type and breast carcinoma.Therefore, research cyclomastopathy class disease has considerable clinical meaning.The attitude of Chinese scholars treatment lays particular stress on and is: when think lump have breast carcinoma may or when dangerous, the excision of just performing an operation; General slight hypertrophy disease, mastalgia are observed.When the violent lump of mastalgia is obvious, then use iodine preparation, lactotropin, progesterone, adrenotrophin, Testosterone, vitamin B6, treatment such as vitamin E, promethazine is observed.
Though above Drug therapy can alleviate some symptoms, be difficult to reach the purpose of healing.Especially adverse consequences also may take place in gonadotherapy.Though China's tradition tcm prescription such as XIAOYAO POWDER or Danzhi Xiaoyao San etc. are effective in cure, also unsatisfactory.
Summary of the invention
The purpose of this invention is to provide a kind of effective Chinese medicine of cyclomastopathy for the treatment of.
From the traditional Chinese medical science " nodules of the breast disease " pathogeny, three of the cause of disease of cyclomastopathy is that irritability is not dredged, and then dysfunction of the spleen in transportation of a specified duration causes stagnation of QI expectorant knot, and newborn network stasis of blood resistance forms.Therapeutic Method is worked as with soothing liver and strengthening spleen, and activating QI to eliminate phlegm, activating collaterals to relieve pain are main.
We are principal agent with the Radix Bupleuri dispersing the stagnated live-QI to relieve the stagnation of QI; And active, the Radix Astragali, Semen Coicis invigorating spleen to remove dampness are auxilliary with Radix Salviae Miltiorrhizae, Radix Angelicae Sinensis, Radix Paeoniae Alba nourishing blood to suppress the hyperactive liver; Nurse one's health mechanism of qi in the heart with Fructus Aurantii, Radix Platycodonis, Pericarpium Citri Reticulatae Viride, Fructus Trichosanthis, Sargassum resolving phlegm and softening hard masses eliminating stagnation, Rhizoma Cyperi, Rhizoma Corydalis promoting the circulation of QI to relieve pain are the assistant treatment.All medicines share, and then the thin spleen of liver is strong, and mechanism of qi is unobstructed, and the expectorant heavily fortified point is soft, and the ruton knot looses and swells and ache from disappearing.
Technical solution of the present invention is: it is to be made by the Chinese medicine of following weight ratio: Radix Bupleuri 5-15, Radix Salviae Miltiorrhizae 8-16, Radix Angelicae Sinensis 10-20, Radix Paeoniae Alba 10-20, Radix Astragali 25-35, Semen Coicis 25-35, Radix Platycodonis 8-12, Fructus Aurantii 8-12, Pericarpium Citri Reticulatae Viride 8-12, Fructus Trichosanthis 10-20, Sargassum 10-20, Rhizoma Cyperi 8-12, Rhizoma Corydalis 10-20.
The weight ratio that said medicine is formed is preferably: Radix Bupleuri 10, Radix Salviae Miltiorrhizae 12, Radix Angelicae Sinensis 15, the Radix Paeoniae Alba 15, the Radix Astragali 30, Semen Coicis 30, Radix Platycodonis 10, Fructus Aurantii 10, Pericarpium Citri Reticulatae Viride 10, Fructus Trichosanthis 15, Sargassum 15, Rhizoma Cyperi 10, Rhizoma Corydalis 15.
Choose Chinese crude drug by the said medicine composition, screening is cleaned, and decocts, and reduced-pressure backflow concentrates, and spray granulation is packed the Chinese medicine granules of making at last.
This medicine patient over several years generally reflects well, and curative effect can increase listing Chinese patent medicine such as peaceful with RUKANG PIAN, breast and compare favourably.So far, treatment cyclomastopathy accumulative total has 3123 routine patients.Through clinical observation, prove that the present invention has original curative effect to all kinds of cyclomastopathies.Now from can estimate 567 routine cases, curative effect is summed up and is seen the following form:
The clinical efficacy summary sheet of breast peaceful (No. 3) treatment cyclomastopathy
The specific embodiment
Embodiment 1
The weight ratio that medicine is formed is: Radix Bupleuri 10, Radix Salviae Miltiorrhizae 12, Radix Angelicae Sinensis 15, the Radix Paeoniae Alba 15, the Radix Astragali 30, Semen Coicis 30, Radix Platycodonis 10, Fructus Aurantii 10, Pericarpium Citri Reticulatae Viride 10, Fructus Trichosanthis 15, Sargassum 15, Rhizoma Cyperi 10, Rhizoma Corydalis 15.Choose Chinese crude drug by the said medicine composition, screening is cleaned, and decocts, and reduced-pressure backflow concentrates, and spray granulation is packed the Chinese medicine granules of making at last.
Embodiment 2
It is to be made by the Chinese medicine of following weight ratio: Radix Bupleuri 5, Radix Salviae Miltiorrhizae 8, Radix Angelicae Sinensis 20, the Radix Paeoniae Alba 20, the Radix Astragali 25, Semen Coicis 25, Radix Platycodonis 12, Fructus Aurantii 12, Pericarpium Citri Reticulatae Viride 12, Fructus Trichosanthis 10, Sargassum 20, Rhizoma Cyperi 12, Rhizoma Corydalis 10.Choose Chinese crude drug by the said medicine composition, screening is cleaned, and decocts, and reduced-pressure backflow concentrates, and spray granulation is packed the Chinese medicine granules of making at last.
Embodiment 3
It is to be made by the Chinese medicine of following weight ratio: Radix Bupleuri 8, Radix Salviae Miltiorrhizae 10, Radix Angelicae Sinensis 15, the Radix Paeoniae Alba 13, the Radix Astragali 25, Semen Coicis 35, Radix Platycodonis 8, Fructus Aurantii 12, Pericarpium Citri Reticulatae Viride 10, Fructus Trichosanthis 16, Sargassum 16, Rhizoma Cyperi 12, Rhizoma Corydalis 20.Choose Chinese crude drug by the said medicine composition, screening is cleaned, and decocts, and reduced-pressure backflow concentrates, and spray granulation is packed the Chinese medicine granules of making at last.
Embodiment 4
It is to be made by the Chinese medicine of following weight ratio: Radix Bupleuri 10, Radix Salviae Miltiorrhizae 12, Radix Angelicae Sinensis 18, the Radix Paeoniae Alba 17, the Radix Astragali 30, Semen Coicis 32, Radix Platycodonis 9, Fructus Aurantii 11, Pericarpium Citri Reticulatae Viride 10, Fructus Trichosanthis 11, Sargassum 17, Rhizoma Cyperi 9, Rhizoma Corydalis 16.Choose Chinese crude drug by the said medicine composition, screening is cleaned, and decocts, and reduced-pressure backflow concentrates, and spray granulation is packed the Chinese medicine granules of making at last.
Embodiment 5
It is to be made by the Chinese medicine of following weight ratio: Radix Bupleuri 7, Radix Salviae Miltiorrhizae 11, Radix Angelicae Sinensis 16, the Radix Paeoniae Alba 13, the Radix Astragali 27, Semen Coicis 31, Radix Platycodonis 11, Fructus Aurantii 11, Pericarpium Citri Reticulatae Viride 10, Fructus Trichosanthis 19, Sargassum 13, Rhizoma Cyperi 10, Rhizoma Corydalis 18.Choose Chinese crude drug by the said medicine composition, screening is cleaned, and decocts, and reduced-pressure backflow concentrates, and spray granulation is packed the Chinese medicine granules of making at last.
Claims (2)
1. medicine that is used for the treatment of cyclomastopathy, it is characterized in that: it is to be made by the Chinese medicine of following weight ratio: Radix Bupleuri 5-15, Radix Salviae Miltiorrhizae 8-16, Radix Angelicae Sinensis 10-20, Radix Paeoniae Alba 10-20, Radix Astragali 25-35, Semen Coicis 25-35, Radix Platycodonis 8-12, Fructus Aurantii 8-12, Pericarpium Citri Reticulatae Viride 8-12, Fructus Trichosanthis 10-20, Sargassum 10-20, Rhizoma Cyperi 8-12, Rhizoma Corydalis 10-20.
2. the medicine that is used for the treatment of cyclomastopathy according to claim 1 is characterized in that: the weight ratio that said medicine is formed is preferably: Radix Bupleuri 10, Radix Salviae Miltiorrhizae 12, Radix Angelicae Sinensis 15, the Radix Paeoniae Alba 15, the Radix Astragali 30, Semen Coicis 30, Radix Platycodonis 10, Fructus Aurantii 10, Pericarpium Citri Reticulatae Viride 10, Fructus Trichosanthis 15, Sargassum 15, Rhizoma Cyperi 10, Rhizoma Corydalis 15.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006100812419A CN100381155C (en) | 2006-05-26 | 2006-05-26 | Medicine for treating mammary glands hyperplasia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006100812419A CN100381155C (en) | 2006-05-26 | 2006-05-26 | Medicine for treating mammary glands hyperplasia |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1883642A CN1883642A (en) | 2006-12-27 |
| CN100381155C true CN100381155C (en) | 2008-04-16 |
Family
ID=37582025
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2006100812419A Expired - Fee Related CN100381155C (en) | 2006-05-26 | 2006-05-26 | Medicine for treating mammary glands hyperplasia |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100381155C (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102600432B (en) * | 2011-10-18 | 2014-03-05 | 宋协勘 | Traditional Chinese medicine for treating hyperplasia of mammary glands |
| CN102716296A (en) * | 2012-06-24 | 2012-10-10 | 李延玲 | Breast nodule pill |
| CN104147507A (en) * | 2014-07-16 | 2014-11-19 | 桂林医学院附属医院 | Oral liquid for eliminating addiction and preparation method thereof |
| CN112370518A (en) * | 2020-11-30 | 2021-02-19 | 江西藤康药业有限公司 | Medicine for treating hyperplasia of mammary glands and preparation method thereof |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1416878A (en) * | 2002-11-29 | 2003-05-14 | 林俊森 | Mastoproliferation treating medicine |
-
2006
- 2006-05-26 CN CNB2006100812419A patent/CN100381155C/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1416878A (en) * | 2002-11-29 | 2003-05-14 | 林俊森 | Mastoproliferation treating medicine |
Non-Patent Citations (1)
| Title |
|---|
| 中医药治疗乳腺增生症78例. 雒维平.中国乡村医药杂志，第12卷第1期. 2005 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1883642A (en) | 2006-12-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101411848B (en) | Black plaster for treating gland hyperplasia and preparation method thereof | |
| CN103071128B (en) | Externally-applied plaster for curing dysmenorrhea | |
| CN102940853B (en) | Navel paste for treating mammary gland hyperplasia diseases | |
| CN102641434A (en) | Capsule capable of promoting blood circulation, removing meridian obstruction and removing paralysis and preparing technology thereof | |
| CN100381155C (en) | Medicine for treating mammary glands hyperplasia | |
| CN101366903B (en) | Traditional Chinese medicine composition for treating climacteric syndrome | |
| CN101721537A (en) | Traditional Chinese medicine for treating rheumatic and rheumatoid arthritis | |
| CN103550697A (en) | Traditional Chinese medicine for treating hysteromyoma | |
| CN103585591A (en) | Traditional Chinese medicine for treating gallstones | |
| CN102988887A (en) | Chinese medicament for treating ovarian cyst | |
| CN102755515B (en) | Traditional Chinese medicine decoction for treating hyperplasia of mammary glands | |
| CN100389815C (en) | Medicine for treating mammary glands hyperplasia | |
| CN103845620A (en) | Traditional Chinese medicine for treating raynaud disease | |
| CN100374133C (en) | Medicine for treating mammary gland hyperplasia | |
| CN100427116C (en) | Medicine for treating proliferation of mammary gland | |
| CN1286500C (en) | Medication for treating numbness of the muscles and painful joints | |
| CN103191369B (en) | Chinese medicinal composition for treating mammary gland hyperplasia | |
| CN105853930A (en) | Traditional Chinese medicine composition for treating depression | |
| CN101085303A (en) | Oral administration traditional Chinese medicine composition for treating hyperplasia of mammary glands | |
| CN104383097A (en) | Traditional Chinese medicine for treating lupus erythematosus | |
| CN103656149A (en) | Preparation method of traditional Chinese medicine prescription for treating insomnia | |
| CN101983712A (en) | Novel medicament for treating coronary heart disease | |
| CN102357193A (en) | Traditional Chinese medicament for curing mammary hyperplasia | |
| CN101249250A (en) | Medicinal liquor preparations for curing stagnation and blood stasis chest stuffiness and pain | |
| CN101396534A (en) | Traditional Chinese medicine for treating mammary gland lobular hyperplasia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20080416 Termination date: 20140526 |